FXYD3 and intrahepatic cholangiocarcinoma: We integrated our in‐house and publicly available single‐cell datasets and performed a joint analysis with high‐resolution spatial transcriptome data obtained from the Visium HD platform (10x Genomics) to elucidate the underlying mechanism by which FXYD3 promotes ICC development (Figure 5A).